Anti-viral Immunity in the Tumor Microenvironment: Implications for the Rational Design of Herpes Simplex Virus Type 1 Oncolytic Virotherapy

被引：0
|
作者：
Paul J. F. Rider
Ifeanyi K. Uche
Larissa Sweeny
Konstantin G. Kousoulas
机构：
[1] Louisiana State University,Division of Biotechnology and Molecular Medicine and Department of Pathobiological Sciences, School of Veterinary Medicine
[2] Louisiana State University Health Sciences Center,undefined
来源：
Current Clinical Microbiology Reports | 2019年 / 6卷
关键词：
HSV; Oncolytic; Herpesvirus; VC2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：193 / 199
页数：6
相关论文
共 50 条
  • [31] Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent mice
    Takakuwa, H
    Goshima, R
    Nozawa, N
    Yoshikawa, T
    Kimata, H
    Nakao, A
    Nawa, A
    Kurata, T
    Sata, T
    Nishiyama, Y
    ARCHIVES OF VIROLOGY, 2003, 148 (04) : 813 - 825
  • [32] Enhancement of systemic tumor immunity for squamous cell carcinoma cells by an oncolytic herpes simplex virus
    Meshii, N.
    Takahashi, G.
    Okunaga, S.
    Hamada, M.
    Iwai, S.
    Takasu, A.
    Ogawa, Y.
    Yura, Y.
    CANCER GENE THERAPY, 2013, 20 (09) : 493 - 498
  • [33] Enhancement of systemic tumor immunity for squamous cell carcinoma cells by an oncolytic herpes simplex virus
    N Meshii
    G Takahashi
    S Okunaga
    M Hamada
    S Iwai
    A Takasu
    Y Ogawa
    Y Yura
    Cancer Gene Therapy, 2013, 20 : 493 - 498
  • [34] IONTOPHORESIS OF ANTI-VIRAL AGENTS FOR HERPES-SIMPLEX VIRUS, TYPE-1 (HSV-1) INFECTED SKIN OF HAIRLESS MICE
    PARK, NH
    GANGAROSA, LP
    HILL, JM
    JOURNAL OF DENTAL RESEARCH, 1978, 57 : 198 - 198
  • [35] Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
    Liu, Xiao-Qin
    Xin, Hong-Yi
    Lyu, Yan-Ning
    Ma, Zhao-Wu
    Peng, Xiao-Chun
    Xiang, Ying
    Wang, Ying-Ying
    Wu, Zi-Jun
    Cheng, Jun-Ting
    Ji, Jia-Fu
    Zhong, Ji-Xin
    Ren, Bo-Xu
    Wang, Xian-Wang
    Xin, Hong-Wu
    DRUG DELIVERY, 2018, 25 (01) : 1950 - 1962
  • [36] Immunoglobulin Genes and Immunity to Herpes Simplex Virus Type 1
    Pandey, Janardan P.
    JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (01): : 143 - 144
  • [37] Evaluation of oncolytic herpes simplex virus type 1 armed with an immunomodulatory function in murine tumor models
    Suzuki, Sayori
    Ino, Yasushi
    Iwai, Miwako
    Fukuhara, Hiroshi
    Todo, Tomoki
    CANCER SCIENCE, 2018, 109 : 276 - 276
  • [38] Innate and acquired immunity to herpes simplex virus type 1
    Halford, WP
    Veress, LA
    Gebhardt, BM
    Carr, DJJ
    VIROLOGY, 1997, 236 (02) : 328 - 337
  • [39] Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunity
    Ying, Liu
    Cheng, Hu
    Xiong, Xu Wen
    Yuan, Lin
    Peng, Zhang Hai
    Wen, Zhong Wen
    Kai, Liang Jian
    Xiao, Xiao
    Jing, Cai
    Qian, Tan Ya
    Liang, Gao Zhi
    Mei, Yan Guang
    Bo, Zhu Wen
    Liang, Peng
    ONCOTARGET, 2017, 8 (15) : 24694 - 24705
  • [40] Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer
    Kohno, SI
    Luo, CH
    Goshima, F
    Nishiyama, Y
    Sata, T
    Ono, Y
    UROLOGY, 2005, 66 (05) : 1116 - 1121
12345